Accordingly, recent studies have demonstrated that P2RY2 expression was elevated in pancreatic ductal adenocarcinoma and in head and neck squamous cell carcinoma (HNSCC), and its inhibition suppressed cancer cell growth both in vitro and in vivo [28,77]. The gene discussed is P2RY2; the disease is pancreatic ductal adenocarcinoma.